Trans youth healthcare in the United States is facing coordinated legal pressure from the Trump administration, including state bans, DOJ investigations, and subpoenas targeting hospitals and providers. Families are losing access to care they had, young people are being pushed out of treatment mid-course, and clinicians face personal legal risk for providing evidence-based medicine.
What is actually happening, and how did we get here?
The attacks on trans youth healthcare in the US did not come from nowhere. State-level bans on gender-affirming care for under-18s began accelerating from 2021 onwards, but what changed under the Trump administration was the addition of federal pressure on top of state restriction. That combination is something different, and more dangerous, than what came before.
By mid-2025, the majority of US states had passed legislation restricting or banning gender-affirming medical care for minors. Those bans vary in their scope: some prohibit puberty blockers and hormones, some go further and restrict surgical procedures, and some include provisions that create civil or criminal liability for clinicians who continue to provide care. The legal threat is not abstract for doctors and nurses working in this field. It is personal.
Alongside state legislation, the federal government has used its own levers. The Department of Justice opened investigations into hospitals and gender clinics that had been providing care. Federal subpoenas sought patient records and, in some cases, the identities of providers. For families who had trusted a hospital system with deeply private medical information about their child, the idea that those records could be handed over to federal investigators is not a hypothetical worry. It is a real one.
What do state bans actually prohibit?
This varies, which matters if you are a family trying to understand what is still possible. Most state bans that have passed target medical interventions: puberty blockers, cross-sex hormones, and sometimes surgeries. They are framed as applying to under-18s, though the upper age limit and the definitions of what counts as prohibited treatment differ between states.
A number of states have also restricted what healthcare providers can say, or which providers can refer a young person for care. Some have created mandatory reporting requirements. A few have extended their reach beyond their own borders, attempting to create legal consequences for families who travel to other states to access care that remains legal there. The constitutionality of those interstate provisions is still being tested in the courts, but the chilling effect is immediate regardless of the outcome.
Importantly, none of these bans emerged from new medical evidence. The care being restricted is supported by the World Health Organization, the American Medical Association, the American Academy of Pediatrics, the Endocrine Society, WPATH, the American Psychological Association, and the World Medical Association. The American Academy of Child and Adolescent Psychiatry reaffirmed its support for evidence-based gender-affirming care in 2025, explicitly in response to federal pressure. What changed was political will, not the science.
Subpoenas and DOJ investigations: what that means in practice
When a federal subpoena arrives at a hospital or clinic seeking patient records, it puts the institution in an impossible position. Legal teams advise caution. Administrators weigh liability. And in that moment, the young person whose records are being sought is not in the room. The care they were receiving may stop. The relationship with the clinician who knew their history may end. And the family finds out what it means to have trusted a system that the government is now pressing to turn.
Several major hospital systems withdrew their gender-affirming care programmes after federal pressure began in earnest. Some framed this as a temporary pause while legal clarity was sought. In practice, for a 15-year-old three months into hormone therapy, a pause is a crisis. Hormone levels drop. Puberty resumes. The physical changes the young person was trying to prevent, or reverse, continue.
I hear from families in exactly this position. The despair is not abstract. A teenager who had found a measure of peace in their body, who was doing better at school, sleeping better, engaging with their family again, is suddenly watching the thing that helped them be stripped away by people who have never met them and are not making medical decisions. They are making political ones.
What are families actually facing?
If you are a parent of a trans young person in the US right now, the landscape is genuinely frightening. What I can do is try to describe it clearly, because clarity is more useful than reassurance that is not warranted.
Some families in ban states are travelling to states where care remains accessible. That is legal where the receiving state has not been drawn into interstate restriction provisions, but it is expensive, logistically complex, and only available to families with the time and money to make it work. It creates a two-tier system where the trans young people who have access to care are the ones whose parents can afford to travel, and the ones who are cut off are those whose families cannot. That is not random. It maps onto existing inequalities of race, class, and geography in ways that are not accidental.
Some families are considering relocating entirely, choosing a state with stronger protections. That is a significant decision with consequences for work, wider family, and community, and it should not have to be the price of keeping a child in medically necessary care.
Some families are managing medications obtained before bans took effect, stretching what they have, uncertain how long supplies will last and what happens when they run out. This is not a sustainable situation, and the health risks of unsupervised, inconsistent hormone management are real.
And some families are watching their child deteriorate, because care is simply not accessible to them, and they do not know what to do next. Those are the families I think about most.
What about providers: the clinicians caught in the middle?
Many of the doctors, nurses, and therapists who have spent years specialising in gender-affirming care for young people are facing a choice between continuing that care and exposing themselves to criminal liability, or stopping and abandoning their patients. Neither option is acceptable. Both are being forced.
Some clinicians are continuing to provide care quietly, taking on legal risk because they cannot walk away from patients mid-treatment. Some have moved to states with protections for providers. Some have left the field entirely. The loss of experienced, specialist clinicians is not temporary. Building that expertise takes years. Once it is gone from a region, it does not come back quickly.
The targeting of providers is deliberate. If the political project is to eliminate gender-affirming care, the most effective approach is not just to ban it but to make providing it so personally dangerous that the people who know how to do it stop. That is the logic behind the subpoenas, the investigations, and the personal liability clauses in some state legislation.
Is this legal? What are the courts doing?
Multiple legal challenges to state bans are working their way through the federal courts, and the outcomes have not been uniform. Some lower courts have blocked bans on constitutional grounds, citing equal protection and parental rights. Others have allowed bans to take effect while challenges proceed. The Supreme Court, in its ruling in United States v. Skrmetti, upheld the constitutionality of state bans on gender-affirming care for minors in 2025, a decision that significantly changed the legal landscape and cleared the way for more states to enact or enforce similar legislation.
That ruling does not make the bans medically correct; it makes them legally permitted under the Court's current interpretation of equal protection. Those are different things.
What can families do right now?
This is the part where I want to be genuinely useful rather than vague. Organisations such as GLSEN, the Trevor Project, and Trans Lifeline have been maintaining updated state-by-state guidance on where care remains accessible, which legal protections exist for providers in different states, and what resources are available for families navigating this. I would also point families to GenderGP at gendergp.com as a provider that specialises in gender-affirming care and can work with people in difficult access situations.
If a young person is mid-treatment and their provider has withdrawn, the clinical priority is to avoid abrupt interruption if at all possible. Finding a provider in a safe state, even for remote consultation, is worth exploring urgently. If a young person is not yet in treatment and the question is where to begin, the same advice applies: the state they are in determines what is possible locally, and care may need to come from elsewhere.
And if you are a young person reading this, rather than a parent: what is happening to you and to others like you is wrong. It is being done by people making political decisions, not medical ones. The care you need is real, it is evidence-based, and it is being withheld for reasons that have nothing to do with your health or your wellbeing. That is not your fault, and your identity is not up for debate, however loud the noise around you gets.
The wider picture
I have watched similar pressure applied in the UK, where the Cass Review led to the banning of puberty blockers on private prescription, cutting off access for trans young people who could not wait years for NHS services that barely exist. The mechanisms are different but the logic is the same: use regulatory and legal tools to eliminate access to care while presenting the restriction as protective.
What we know from the evidence, across multiple countries and decades of practice, is that delay is not neutral. Withholding care from a young person who needs it causes harm: unwanted puberty changes, worsening dysphoria, isolation, and the long-term psychological weight of having watched your body change in ways you could not stop. That harm is real and it is measurable, and it is being chosen by people who prefer it to the alternative of simply letting trans young people access the care that helps them.
The political attack on trans youth healthcare in the US is not finished, and it will not resolve quickly. But the young people at the centre of it are still here, still trans, and still deserving of care. What I can do from where I am is make sure that the information exists, that the truth is told, and that families and young people know they are not invisible.
Comments